Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Q2 2025 earnings

Reported August 5, 2025 · Before market open

Revenue$200.5MMiss by $19.7M
EPS$0.68Miss by $0.10
Revenue estimate$220.2M
EPS estimate$0.78

Next report

Aug 4, 2026 (In 5 days)
Revenue estimate$249.0M
EPS estimate$0.97

Financials

Q2 2025

Income statement

See full
Revenue$200.5M+16.0%
Gross profit$162.3M+15.4%
Operating income$48.2M+126%
Net income$39.8M+243%
EPS (diluted)$0.68+240%

Balance sheet

See full
Cash & equivalents$546.1M+72.1%
Total debt$173.4M-8.3%
Total equity$773.1M+43.5%
Total assets$1.1B+29.1%

Cash flow

See full
Operating cash flow$79.3M+86.1%
CapEx$4.0K-99.4%
Free cash flow$79.3M+88.9%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.84B+7.5%
Enterprise value$1.47B-7.3%
P/E10.2×-4.7×
P/S2.4×-0.2×

Profitability

See full
Gross margin78.3%-1.1pp
Operating margin28.7%+1.6pp
Net margin23.4%+5.9pp
FCF margin33.5%+1.1pp

Returns & leverage

See full
Return on equity27.6%+5.1pp
Debt / equity0.2×-0.1×
Current ratio3.8×+0.7×

Segments

By segment

See full
Rare Neurological Diseases$200.5M+16.0%

Versus estimates

Revenue

Q1 2026$215.4MMiss by $5.5MQ4 2025$243.8MBeat by $3.5MQ3 2025$239.5MMiss by $581.2K
Q2 2025$200.5MMiss by $19.7M
Q1 2025$184.7MMiss by $21.3MQ4 2024$201.3MBeat by $18.1M

Diluted EPS

Q1 2026$0.55Miss by $0.21Q4 2025$0.38Miss by $0.46Q3 2025$0.87Miss by $0.05
Q2 2025$0.68Miss by $0.10
Q1 2025$0.78Beat by $0.19Q4 2024$0.85Beat by $0.11

Ask the moment Harmony Biosciences Holdings, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Harmony Biosciences Holdings, Inc. report Q2 2025 earnings?
Harmony Biosciences Holdings, Inc. (HRMY) reported Q2 2025 earnings on August 5, 2025 before market open.
What were Harmony Biosciences Holdings, Inc.'s Q2 2025 revenue and EPS?
Harmony Biosciences Holdings, Inc. reported revenue of $200.5M and eps of $0.68 for Q2 2025.
Did Harmony Biosciences Holdings, Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $220.2M by $19.7M. EPS missed the consensus estimate of $0.78 by $0.10.
How did Harmony Biosciences Holdings, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 16.0% from $172.8M a year earlier and eps grew 240.0% from $0.20.
Where can I find Harmony Biosciences Holdings, Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001558370-25-010185) directly on SEC EDGAR. The filing index links above go to sec.gov.